CASC3 Antikörper (pTyr181)
(2 Referenzen)-
- Target Alle CASC3 Antikörper anzeigen
- CASC3 (Cancer Susceptibility Candidate 3 (CASC3))
-
Bindungsspezifität
- pTyr181
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CASC3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic phosphopeptide of CASC3.
- Kreuzreaktivität
- Human
- Immunogen
- Synthetic phosphopeptide (conjugated with KLH) corresponding to amino acids 166-196 residues surrounding Y181 of human CASC3.
- Top Product
- Discover our top product CASC3 Primärantikörper
-
anti-Cancer Susceptibility Candidate 3 (CASC3) antibody
CASC3 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 206-236) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB10332 unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 159-188) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB15327 unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 604-703) antibodyCASC3 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 159-188) antibodyCASC3 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (N-Term) antibodyCASC3 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schwein, Meerschweinchen, Fledermaus, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (C-Term) antibodyCASC3 Reaktivität: Human, Maus WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 202-233), (C-Term) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (Tyr181) antibodyCASC3 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot (1:1000)
Immunohistochemistry (1:10-50)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Barentsz, a new component of the Staufen-containing ribonucleoprotein particles in mammalian cells, interacts with Staufen in an RNA-dependent manner." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 23, Issue 13, pp. 5778-88, (2003) (PubMed).
: "Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer." in: Oncogene, Vol. 21, Issue 28, pp. 4422-34, (2002) (PubMed).
-
: "Barentsz, a new component of the Staufen-containing ribonucleoprotein particles in mammalian cells, interacts with Staufen in an RNA-dependent manner." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 23, Issue 13, pp. 5778-88, (2003) (PubMed).
-
- Target
- CASC3 (Cancer Susceptibility Candidate 3 (CASC3))
- Andere Bezeichnung
- CASC3 (CASC3 Produkte)
- Synonyme
- BTZ antikoerper, MLN51 antikoerper, Btz antikoerper, Mln51 antikoerper, CASC3 antikoerper, btz antikoerper, mln51 antikoerper, StMLN51 antikoerper, barentsz antikoerper, XlMLN51 antikoerper, cancer susceptibility 3 antikoerper, cancer susceptibility candidate 3 antikoerper, protein CASC3 antikoerper, cancer susceptibility 3 S homeolog antikoerper, CASC3 antikoerper, Casc3 antikoerper, casc3 antikoerper, casc3.S antikoerper
- Gen-ID
- 22794
-
